|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,233.90 INR | +1.99% |
|
+1.31% | +9.76% |
| 23/07 | Shares in Generic-Drug Makers Fall After Trump's Tariff Plan -- Update | DJ |
| 22/07 | Shares in Generic-Drug Makers Fall After Trump's Tariff Plan | DJ |
| Market Cap | 618B 6.47B 5.62B 5.22B 4.82B 9.07B 9.24B 61.83B 24.21B 307B 24.31B 23.78B 1,032B | P/E 2026 |
44.2x | P/E 2027 * | 26.3x |
|---|---|---|---|---|---|
| Enterprise Value | 579B 6.06B 5.27B 4.89B 4.51B 8.5B 8.65B 57.9B 22.67B 287B 22.77B 22.27B 967B | EV / Sales 2026 |
3.51x | EV / Sales 2027 * | 3.48x |
| Free-Float |
51.03% | Yield 2026 |
0.12% | Yield 2027 * | 0.24% |
Last Transcript: Glenmark Pharmaceuticals Limited
| 1 day | +1.99% | ||
| 1 week | +1.31% | ||
| Current month | +1.34% | ||
| 1 month | +1.34% | ||
| 3 months | -7.16% | ||
| 6 months | +10.81% | ||
| Current year | +9.76% |
| 1 week | 2,178.2 |  | 2,270.2 |
| 1 month | 2,142.8 | | 2,326.1 |
| Current year | 1,842 | | 2,474 |
| 1 year | 1,792.6 | | 2,474 |
| 3 years | 722.1 | | 2,474 |
| 5 years | 348.5 | | 2,474 |
| 10 years | 161.65 | | 2,474 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 56 | 01/01/2000 | |
Anurag Mantri
DFI | Director of Finance/CFO | 54 | 27/05/2025 |
Indrajit Bose
PSD | President | - | 15/09/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Cherylann Pinto
BRD | Director/Board Member | 58 | - |
| Chairman | 56 | 12/05/2011 | |
| Director/Board Member | 85 | 14/08/2009 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.99% | +1.31% | +3.73% | +183.54% | 6.47B | |
| -0.53% | +1.87% | +14.81% | +74.09% | 50.29B | |
| -1.81% | -0.49% | +51.99% | +112.44% | 37.24B | |
| +0.46% | +5.76% | -5.53% | +25.38% | 12.41B | |
| +1.05% | +1.17% | +13.23% | +78.22% | 11.65B | |
| -0.57% | +0.96% | +31.25% | +132.30% | 9.17B | |
| -2.99% | -2.09% | +41.02% | -8.36% | 7.24B | |
| +1.62% | +2.40% | +15.71% | +34.35% | 6.8B | |
| +0.21% | -5.18% | -34.40% | -1.46% | 5.46B | |
| +0.84% | +0.74% | +23.74% | +104.17% | 4.5B | |
| Average | +0.03% | +1.90% | +15.56% | +73.47% | 15.12B | |
| Weighted average by Cap. | -0.49% | +2.69% | +22.48% | +80.50% |
| 2026 | 2027 * | |
|---|---|---|
| Net sales | 153B 1.6B 1.39B 1.29B 1.19B 2.25B 2.29B 15.31B 6B 76.04B 6.02B 5.89B 256B | 167B 1.75B 1.52B 1.41B 1.3B 2.45B 2.49B 16.68B 6.53B 82.8B 6.56B 6.41B 278B |
| Net income | 20.53B 215M 187M 173M 160M 301M 307M 2.05B 804M 10.2B 808M 790M 34.29B | 23.28B 244M 212M 197M 181M 342M 348M 2.33B 912M 11.56B 916M 896M 38.89B |
| Net Debt | -39.29B -412M -358M -332M -306M -577M -587M -3.93B -1.54B -19.52B -1.55B -1.51B -65.63B | -37.12B -389M -338M -314M -289M -545M -555M -3.71B -1.45B -18.44B -1.46B -1.43B -62B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 31/07/26 | INR 2,233.90 | +1.99% | 371,153 |
| 30/07/26 | INR 2,190.30 | -3.16% | 451,791 |
| 29/07/26 | INR 2,261.70 | +3.53% | 593,720 |
| 28/07/26 | INR 2,184.60 | -0.52% | 490,034 |
| 27/07/26 | INR 2,196.00 | +0.18% | 593,586 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GLENMARK Stock
Select your edition
All financial news and data tailored to specific country editions
